Equity
€3,000 from €140,221 in 2023
Equity fell by 98% in 2 years.
DR.SP
Lifetime
5 annual accounts with figures on one time axispeak €117,974 (2024)
€108,935▼ 7.7%
peak €90,997 (2024)
€80,204▼ 11.9%
peak €140,221 (2023)
€3,000unchanged
€99,338▼ 16.5%
Board1 name since 2021
1 director
Documentsfilings and deeds
31-03-2026122 days before the deadline
2025micro format
Registered office moved from Bornem to Edegem 23-04Dividend €80,204Debts from €118,995 to €99,338
Key points
from the 2025 annual accountsTurnover
≈ €200,000 estimated
The micro format states no turnover.
Debts
€99,338 97% of the balance sheet
Filings
5 annual accounts since 2021
The last five annual accounts were filed 25 to 122 days before the end of the period.
Starting capital
€3,000 100 shares
Position in the sector
€3,000
Less equity than 93% of companies in human health. Sector median €125,045 · 21,332 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,156 companies had the same profile as DR.SP has now. Each dot stands for 6 companies, two years later.
94.1%
were still trading
2.8%
stopped another way
3.0%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,156 companies, not a prediction for DR.SP. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0778335720
Registered office moved from Bornem to Edegem
New registered office: Prins Boudewijnlaan 265 A 103, 2650 EDEGEM · Previous registered office: Kloosterstraat 67/101, 2880 BORNEM · Board meeting of 01-04-2025 · Gazette deed
Registered-office move
Board meeting of 07-11-2023 · Gazette deed
Incorporation
Founding capital of €3,000, 100 shares · Founder: · Appointment: (director) · published on 09-12-2021 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DR.SP Edegem | €102,338 | €108,935 | 2.9% | - |
| PHTN-Médical Modave | €110,820 | €119,460 | 46.8% | - |
| Dr. Bruno Waked, gastro-enteroloog Merelbeke-Melle | €88,603 | €112,473 | 93.0% | - |
| Dr. Marie Jacobs Leuven | €102,527 | €125,942 | 99.2% | - |
| Dr. Céline Nysten Puurs-Sint-Amands | €82,549 | €111,007 | 0.1% | - |
| MASARO Zandhoven | €99,145 | €90,854 | 7.1% | - |
| Dr. Heidi Michielsen Mortsel | €111,795 | €137,552 | 84.1% | - |
These companies have the same main activity as DR.SP: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €82,500 and €112,000, founded between 2021 and 2022.
Official details
Source: KBO- Status
- Active since 07-12-2021Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.324.863.6332650 Edegem, since 07-12-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 10-11-2025
Annual accounts 2025
- €102,338▼ 16.1%
- Filing
- Filed on 31-03-2026, 122 days before the end of the filing period
Insights on DR.SP
DR.SP files the micro format. That format states no turnover. The gross margin rose from €20,848 in 2021 to €108,935 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DR.SP
- What is the company number of DR.SP?
- The company number of DR.SP is 0778.335.720. The VAT number is the same number with BE in front: BE 0778.335.720.
- Where is DR.SP based?
- The registered office is at Prins Boudewijnlaan 265 A, 2650 Edegem.Company details
- What does DR.SP do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DR.SP?
- DR.SP is a private limited company (BV).
- When was DR.SP founded?
- DR.SP was founded on 07-12-2021.
- Is DR.SP still active?
- Yes, DR.SP is an active enterprise in the KBO register.
- What is the turnover of DR.SP?
- The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €108,935 and 40 comparable companies (NACE 86220). It probably lies between €170,000 and €270,000.Financials
- Is DR.SP profitable?
- In financial year 2025, DR.SP made a profit of €80,204.
- Where can I find the annual accounts of DR.SP?
- DR.SP filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR.SP due?
- DR.SP must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.